Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotoxic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04465214
What this trial is testing

Mobile Sensor Technologies to Assess General Symptomology of People With Cancer

Who this might be right for
NeoplasmsSolid TumorsProstate Cancer+2 more
National Cancer Institute (NCI) 49
Not applicableUnknownNCT05494320
What this trial is testing

The Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

Who this might be right for
Gastrointestinal Cancer
Ain Shams University 120
Early research (Phase 1)Active Not RecruitingNCT03016377
What this trial is testing

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

Who this might be right for
Acute Lymphoblastic LeukemiaImmune System DiseasesImmunoproliferative Disorders
UNC Lineberger Comprehensive Cancer Center 15
Early research (Phase 1)Study completedNCT01357213
What this trial is testing

Phase 1 PK Study of XOMA 3AB

Who this might be right for
Botulism
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)UnknownNCT05695313
What this trial is testing

Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXEL

Who this might be right for
Breast Cancer
Centre Georges Francois Leclerc 60
Testing effectiveness (Phase 2)Study completedNCT00078845
What this trial is testing

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Who this might be right for
Breast CancerLung CancerNeurotoxicity+3 more
M.D. Anderson Cancer Center 24
Not applicableStudy completedNCT02890030
What this trial is testing

The Platinum Study Comparison Group

Who this might be right for
Testicular Neoplasms
Lawrence Einhorn 102
Post-approval studies (Phase 4)Ended earlyNCT02435095
What this trial is testing

Antipsychotic Induced Structural and Functional Brain Changes

Who this might be right for
Schizophrenia
RWTH Aachen University 174
Post-approval studies (Phase 4)Ended earlyNCT00754767
What this trial is testing

L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeurotoxicity
HealthPartners Institute 2
Testing effectiveness (Phase 2)Study completedNCT01176721
What this trial is testing

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
cerbomed GmbH 20
Post-approval studies (Phase 4)Ended earlyNCT03616639
What this trial is testing

Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function

Who this might be right for
PainTerminal IllnessRenal Impairment
Maastricht University Medical Center 8
Testing effectiveness (Phase 2)UnknownNCT05566457
What this trial is testing

HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 92
Not applicableStudy completedNCT02429921
What this trial is testing

High-selenium Lentils Versus Arsenic Toxicity

Who this might be right for
Arsenic Poisoning
University of Calgary 400
Not applicableUnknownNCT04250038
What this trial is testing

Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile Neutropenia

Who this might be right for
PharmacokineticsPharmacodynamicsCefepime
Universitaire Ziekenhuizen KU Leuven 98
Large-scale testing (Phase 3)Active Not RecruitingNCT00978458
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System TumorsNeurotoxicity
Eastern Cooperative Oncology Group 540
Large-scale testing (Phase 3)Study completedNCT00027963
What this trial is testing

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

Who this might be right for
NeurotoxicityPain
Alliance for Clinical Trials in Oncology 100
Testing effectiveness (Phase 2)UnknownNCT02235948
What this trial is testing

Effects of Folic Acid Supplementation on Arsenic Lowering

Who this might be right for
Arsenic PoisoningToxic Effect of Arsenic and Its Compounds
Wenzhou Medical University 450
Testing effectiveness (Phase 2)Looking for participantsNCT05519579
What this trial is testing

Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Northside Hospital, Inc. 20
Not applicableStudy completedNCT01982591
What this trial is testing

Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Who this might be right for
Male Breast CancerNeurotoxicityPeripheral Neuropathy+6 more
Fox Chase Cancer Center 115
Post-approval studies (Phase 4)Study completedNCT03685500
What this trial is testing

A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)

Who this might be right for
HIV Infections
Fundacion SEIMC-GESIDA 78
Next Page